Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ebersole, US

Dwayne E. Ebersole, Lancaster, PA US

Patent application numberDescriptionPublished
20080275989OPTIMIZING VIRTUAL INTERFACE ARCHITECTURE (VIA) ON MULTIPROCESSOR SERVERS AND PHYSICALLY INDEPENDENT CONSOLIDATED NICS - Optimization of the Virtual Interface Architecture (VIA) on Multiprocessor Servers using Physically Independent Consolidated NICs (Network Interface Cards) allows for improved throughput, increased resiliency and transparent fail-over; and also by hiding the actual NICs involved in particular data transactions, enables operations with substantially unmodified applications software.11-06-2008
20090043886OPTIMIZING VIRTUAL INTERFACE ARCHITECTURE (VIA) ON MULTIPROCESSOR SERVERS AND PHYSICALLY INDEPENDENT CONSOLIDATED VICs - Optimization of the Virtual Interface Architecture (VIA) on Multiprocessor Servers using Physically Independent Consolidated NICs (Network Interface Cards) allows for improved throughput, increased resiliency and transparent fail-over; and also by hiding the actual NICs involved in particular data transactions, enables operations with substantially unmodified applications software.02-12-2009
20090172301INTELLIGENT NETWORK INTERFACE CARD (NIC) OPTIMIZATIONS - Intelligent NIC optimizations includes system and methods for Token Table Posting, use of a Master Completion Queue, Notification Request Area (NRA) associated with completion queues, preferably in the Network Interface Card (NIC) for providing notification of request completions, and what we call Lazy Memory Deregistration which allows non-critical memory deregistration processing to occur during non-busy times. These intelligent NIC optimizations which can be applied outside the scope of VIA (e.g. iWARP and the like), but also support VIA.07-02-2009

Garett Ebersole, New Haven, CT US

Patent application numberDescriptionPublished
20120094005Methods of Forming Self-Supporting Films for Delivery of Therapeutic Agents - The present disclosure relates to self-supporting films for delivery of a therapeutic agent containing at least one hydrophobic polymer and at least one therapeutic agent. Methods of forming the self-supporting films are also disclosed.04-19-2012

Garrett Ebersole, Southington, CT US

Patent application numberDescriptionPublished
20100087840WOUND CLOSURE MATERIAL - Articles are provided having no orientation or a multi-directional orientation. Such articles may be in the form of films, ribbons, sheets, and/or tapes and may be utilized as buttresses with a surgical stapling apparatus or as reinforcing means for suture lines. The articles may be produced with etchings on at least a part of a surface of the article.04-08-2010
20110230910SURGICAL GRASPER WITH INTEGRATED PROBE - A surgical instrument for minimally invasive surgical procedures having a handle portion, an elongated body portion extending distally from the handle portion, an end effector movable between a first position and a second position, and an elongated tissue probe movably positioned within the elongated portion. The probe is movable between a retracted position and an advanced position, wherein movement of the probe moves the end effector from the first position to the second position.09-22-2011
20110232838Therapeutic Implant - Surgical implants of the present disclosed include a film comprising a first therapeutic agent and a mesh comprising a second therapeutic agent. The surgical implant includes a film in direct contact with a mesh. The first therapeutic agent may be released at a first rate and the second therapeutic agent may be released at a second rate.09-29-2011
20110236459Therapeutic Implant - Surgical implants of the present disclosed include a film comprising a first therapeutic agent and a mesh comprising a second therapeutic agent. The surgical implant includes a film in direct contact with a mesh. The first therapeutic agent may be released at a first rate and the second therapeutic agent may be released at a second rate.09-29-2011
20110236460Therapeutic Implant - Surgical implants of the present disclosed include a film comprising a first therapeutic agent and a mesh comprising a second therapeutic agent. The surgical implant includes a film in direct contact with a mesh. The first therapeutic agent may be released at a first rate and the second therapeutic agent may be released at a second rate.09-29-2011

Garrett Ebersole, New Haven, CT US

Patent application numberDescriptionPublished
20120009240Films for Delivery of a Therapeutic Agent - The present disclosure relates to self-supporting films for delivery of a therapeutic agent containing at least one hydrophobic polymer and at least one therapeutic agent. Methods of forming the multilayer films are also disclosed.01-12-2012
20120010637Self-Detachable Medical Devices - The present disclosure relates to self-detachable medical devices containing a detachable film layer and polymeric film layer.01-12-2012
20120094004Methods of Forming Self-Supporting Films for Delivery of Therapeutic Agents - The present disclosure relates to self-supporting films for delivery of a therapeutic agent containing at least one hydrophobic polymer and at least one therapeutic agent. Methods of forming the self-supporting films are also disclosed.04-19-2012
20120095418Self-Supporting Films For Delivery Of Therapeutic Agents - The present disclosure relates to self-supporting films for delivery of a therapeutic agent containing at least one hydrophobic polymer and at least one therapeutic agent. Methods of forming the self-supporting films are also disclosed.04-19-2012

Jeffrey L. Ebersole, Lexington, KY US

Patent application numberDescriptionPublished
20080300798CARDIBIOINDEX/CARDIBIOSCORE AND UTILITY OF SALIVARY PROTEOME IN CARDIOVASCULAR DIAGNOSTICS - Embodiments of the invention include methods by which cardiac biomarkers are assigned an index (cardiovascular biomarker index-cardiobioindex, CBI) as a means to describe the utility of each biomarker, or combination of biomarkers for risk evaluation, diagnosis or prognosis of cardiovascular disease status.12-04-2008

Jeffrey T. Ebersole, Columbia City, IN US

Patent application numberDescriptionPublished
20100100100SURGICAL INSTRUMENT AND METHOD OF USE FOR INSERTING AN IMPLANT BETWEEN TWO BONES - The surgical instrument includes a handle assembly and an elongate body that has first and second ends with the first end being located adjacent to the handle assembly and the second end being moveably connected to an implant engagement assembly. The surgical instrument also has a length control mechanism that includes a gripping portion, a drive shaft and a gear assembly. The surgical instrument further has a locking mechanism that includes a gripping portion, a connecting rod and a coupling end. The length control mechanism functions to adjust the overall length of an implant that is held by the implant engagement assembly before being implanted in vivo. The locking mechanism operates to secure the overall length of the implant following final length adjustment and implantation. A surgical method for using the surgical instrument, a method of fabrication and a spinal implant insertion kit is also disclosed.04-22-2010

Joan Ebersole, Glen Ellyn, IL US

Patent application numberDescriptionPublished
20100131404METHOD AND INTERFACE FOR PRESENTING LAST TRADED QUANTITY INFORMATION - Trading software may receive trading information from an exchange. The trading software may use the trading information to compute an estimate of last traded total sweep quantity. The trading software may also display the last traded total sweep quantity on a trading screen.05-27-2010
20100131405METHOD AND INTERFACE FOR PRESENTING LAST TRADED QUANTITY INFORMATION - Trading software may receive trading information from an exchange. The trading software may use the trading information to compute an estimate of last traded total sweep quantity. The trading software may also display the last traded total sweep quantity on a trading screen.05-27-2010
20100235302System and Method for Displaying Highest and Lowest Traded Prices of Tradable Objects - A client terminal displays on a graphical interface a first indicator of a price associated with a lowest traded price of a tradable object during a predetermined period of time, a second indicator of a price associated with a highest traded price of the tradable object during the predetermined period of time, along with at least one quantity indicator associated with at least one order to buy/order the tradable object. The first indicator, the second indicator, and the at least one quantity indicator are displayed in relation to a static axis of price, and the client terminal dynamically updates the first and second indicator to new lowest and highest traded prices based on market updates received from an exchange.09-16-2010
20100287089METHOD, APPARATUS AND INTERFACE FOR TRANSACTION TOGGLING - A method for submitting transactions from an automated trading tool to an electronic exchange. The method includes defining a proximity limit and automatically generating a transaction for a tradeable object. The method further includes applying the proximity limit to the transaction. When the transaction falls within the defined proximity limit, the transaction is submitted to the exchange. An apparatus and interface for transaction toggling based on proximity limits are also provided.11-11-2010
20100299242System and Method for Displaying Highest and Lowest Traded Price of Tradable Objects - A client terminal displays on a graphical interface a first indicator of a price associated with a lowest traded price of a tradable object during a predetermined period of time, a second indicator of a price associated with a highest traded price of the tradable object during the predetermined period of time, along with at least one quantity indicator associated with at least one order to buy/order the tradable object. The first indicator, the second indicator, and the at least one quantity indicator are displayed in relation to a static axis of price, and the client terminal dynamically updates the first and second indicator to new lowest and highest traded prices based on market updates received from an exchange.11-25-2010
20110040680METHOD, APPARATUS AND INTERFACE FOR TRANSACTION TOGGLING - A method for submitting transactions from an automated trading tool to an electronic exchange. The method includes defining a proximity limit and automatically generating a transaction for a tradeable object. The method further includes applying the proximity limit to the transaction. When the transaction falls within the defined proximity limit, the transaction is submitted to the exchange. An apparatus and interface for transaction toggling based on proximity limits are also provided.02-17-2011
20110213694METHOD, APPARATUS AND INTERFACE FOR TRANSACTION TOGGLING - A method for submitting transactions from an automated trading tool to an electronic exchange. The method includes defining a proximity limit and automatically generating a transaction for a tradeable object. The method further includes applying the proximity limit to the transaction. When the transaction falls within the defined proximity limit, the transaction is submitted to the exchange. An apparatus and interface for transaction toggling based on proximity limits are also provided.09-01-2011
20110225083METHOD AND INTERFACE FOR PRESENTING LAST TRADED QUANTITY INFORMATION - Trading software may receive trading information from an exchange. The trading software may use the trading information to compute an estimate of last traded total sweep quantity. The trading software may also display the last traded total sweep quantity on a trading screen.09-15-2011

Patent applications by Joan Ebersole, Glen Ellyn, IL US

John S. Ebersole, Chesterton, IN US

Patent application numberDescriptionPublished
20100198297Wireless Recording and Stimulation of Brain Activity - Subdural arrays transmit electrocorticogram recordings wirelessly, across the patient's skull, allowing the craniotomy used for surgical placement of the arrays to be completely closed. In various embodiments, the arrays also respond to commands, applying signal patterns to the patient's brain for diagnostic and treatment purposes.08-05-2010

Michael R. Ebersole, Annville, PA US

Patent application numberDescriptionPublished
20110042240APPARATUS AND METHODS FOR TESTING IMPURITY CONTENT IN A PRECIOUS METAL - A precious metal testing apparatus and methods adapted to analyze impurities in a precious metal test sample is described. The testing apparatus contains a test probe that has a replaceable portion and that is connected to a meter to measure resistance. The replaceable portion contains or forms a reservoir that includes at least one electrolyte component, a conductive member, and a fibrous tip. The electrolyte component is fluidly associated with a fiber tip and the conductive member contacts an electrical contact located outside the reservoir. Methods of testing and instructions regarding such methods are also included.02-24-2011

Richard C. Ebersole, Wilmington, DE US

Patent application numberDescriptionPublished
20080293037Sequences Diagnostic For Shrimp Pathogens - Primers have been isolated that are diagnostic for the detection of the infectious hypodermal and hematopoietic necorsis virus (IHHNV). The primers are based on a new portion of the IHHNV genome and may be used in primer directed amplification or nucleic acid hybridization assay methods.11-27-2008
20090061415Sequences Diagnostic For Shrimp Pathogens - Primers have been isolated that are diagnostic for the detection of the taura syndrome virus (TSV). The primers are based on a new portion of the TSV genome and may be used in primer directed amplification or nucleic acid hybridization assay methods.03-05-2009
20100028887METHOD, KIT AND SYSTEM FOR COLLECTING AND PROCESSING SAMPLES FOR DNA AND RNA DETECTION - This invention relates to a method, kit and system for collecting and processing of samples to release and treat DNA and RNA for gene sequence detection. The method described here in provides for rapid and convenient release, and recovery of DNA and RNA from tissues and cellular materials.02-04-2010
20100167303SEQUENCES DIAGNOSTIC FOR SHRIMP PATHOGENS - Primers have been isolated that are diagnostic for the detection of 07-01-2010
20110020794METHOD FOR THE DETECTION OF DIAGNOSTIC RNA - Methods for the direct detection of diagnostic target RNA have been developed, which obviate the need for time consuming RNA purification and isolation procedures.01-27-2011
20120034263SEQUENCES DIAGNOSTIC FOR SHRIMP PATHOGENS - Primers have been isolated that are diagnostic for the detection of the white spot syndrome virus (WSSV). The primers are based on a new portion of the WSSV genome and may be used in primer directed amplification or nucleic acid hybridization assay methods.02-09-2012
20120045753SEQUENCES DIAGNOSTIC FOR SHRIMP PATHOGENS - Primers have been isolated that are diagnostic for the detection of the white spot syndrome virus (WSSV). The primers are based on a new portion of the WSSV genome and may be used in primer directed amplification or nucleic acid hybridization assay methods.02-23-2012

Patent applications by Richard C. Ebersole, Wilmington, DE US

Steven Ebersole, Austin, TX US

Patent application numberDescriptionPublished
20090063435PARAMETER TYPE PREDICTION IN OBJECT RELATIONAL MAPPING - Techniques for object relational mapping in database technologies are described herein. According to one embodiment, in response to a query statement for accessing a relational database, a syntax tree is generated to represent semantic information of the query statement, where the query statement includes a wildcard parameter and is implemented as an object of a SQL. A data type of the wildcard parameter is predicted based on the semantic information obtained from the syntax tree in view of a structure representing the syntax tree. The predicted data type of the wildcard parameter is used to access the corresponding entry of the relational database. Other methods and apparatuses are also described.03-05-2009
20090063436BOOLEAN LITERAL AND PARAMETER HANDLING IN OBJECT RELATIONAL MAPPING - Techniques for object relational mapping in database technologies are described herein. According to one embodiment, in response to a query statement for accessing a relational database, a syntax tree is generated to represent semantic information of the query statement, where the query statement has a boolean parameter and is implemented as an SQL object. A data type of the boolean parameter is predicted based on the semantic information obtained from the syntax tree in view of a structure representing the syntax tree. The boolean parameter is configured to be either a numeric value or a string dependent upon metadata used to map the SQL object to the relational database. Other methods and apparatuses are also described.03-05-2009
20090063781 CACHE ACCESS MECHANISM - Techniques for improving cache accesses in an object-relational mapping space are described herein. In one embodiment, in response to a first cache request received at a first cache API associated with a transaction for updating a data entry of the relational database, the updated data of the data entry is stored in a local cache, where the local cache is one of members of a cache cluster, and an invalidation message is sent to remaining members of the cache cluster to invalidate corresponding cache entries of the remaining members. In response to a second cache request received at a second cache API associated with a transaction for loading data from a data entry of the relational database, the loaded data is stored in the local cache without sending an invalidation message to the remaining members of the cache cluster. Other methods and apparatuses are also described.03-05-2009

Tom Ebersole, Brownsville, TX US

Patent application numberDescriptionPublished
20100022006GAMMA SATELLITE INSULATOR SEQUENCES AND THEIR USE IN PREVENTING GENE SILENCING - Regulatory elements, specifically insulators and transgene constructs containing insulator nucleic acid sequences, are disclosed herein. Methods of using insulators and transgene constructs including insulators to inhibit, delay, or prevent gene silencing are also disclosed herein.01-28-2010